EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS072-00537 
Organism
Homo sapiens 
Tissue/cell
GM19193 
Coordinate
chr12:133020270-133023320 
TF binding sites/motifs
Number: 27             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC-6.92
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC-6.74
JDP2(var.2)MA0656.1chr12:133022644-133022656TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022745-133022757TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022695-133022707GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022796-133022808GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022847-133022859GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022897-133022909GATGACGTCACC+6.92
PRDM1MA0508.2chr12:133021450-133021460TCACTTTCAC+6.02
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10775chr12:133020028-133023469CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr12133021598133021727
chr12133021781133022391
chr12133021534133022956
Number: 1             
IDChromosomeStartEnd
GH12I132443chr12133020139133023744
Enhancer Sequence
TGCGTGGGGT ACTCTTACAC TCACGGGGGT GCCGGGCCCC TGGAACCTGC AACTCACGCA 60
GGATGCTCTT TTAACTTACT CTATTATGTT TCCTGTTTTA TACGGTGCTG TATCGTTGGC 120
TCTGTCTTTA AGATCATTCA CCTTTTCCTC CATGTGTGGT CTGTGAACCC CATCCATTGT 180
AGCCTTGATT TCTAGAAGTT TGGTTTGCAT ATTTTTAAAT GGTCTATGTT TCTACTTAGC 240
TCTTTCAACA CAGGGAATGC AGTCAGGATG ACTGTCAGTG TCTGTCTGGC GATTCTAACA 300
CTTGTGTTAG TTCTGACCAG GATTTCGCAG TGGATTTTTC CTCCCCTTAC GGGTGGGTTT 360
TCCTGCTTCC CCGAATGTAA TCTTTGAATC GATGGCAGAC ATTGTTAACA TCGCCTTTGT 420
TGGGTGTGGA TGTTTGTGTT TATGTGGAAA CATTCCTGCA CCTTTTTCTG GCGTGCGGTT 480
CAGTTACATG GAAAAGGTTT GGCCTCTCAG GTCTTATTTT AAAGTGGCCG TCAGGGCCGA 540
ATGTTCTGCC CATTTTGTCC ACACTAATTA TCCCTCTTTG GGGAGCAAGA CCCTTGTGAG 600
ATGCCACCGC CACCCTCGGG AGGCCTCCAG GCTGGGGGAC GGGCACTGTG GGCTGCTGGT 660
GTAGGGCCGG ACGCTCTCTG ACAGTGTTGC CCCTGGCCTC CGGCGGCTTC CTCCCAAGCT 720
GGGTTGGGGC TCTTCTGAAC GCTCCCCTCC ATGCCCTGTC CTGGGAACTT TAACCCTCTG 780
GGCCTCCCGG AGCCCTCTGT CTCCCCTGTC CCAGGGGGTC TGCTGGGCTC CACCGGGCCC 840
CGCCCTGAAT GCAGCCTGGA GCAACGCTGG AGGCCGGGGC TAGGAAACTG TGAGCCCCGC 900
CTTGTCTGTG TCTTTCTCAG GGATTCTCGT CCTTTCCAAC CTGGTGCCCG ATGTCCGGAA 960
GCACCTCTTC TGTGTTTTCA AATGGGAGAG CGAATCCAGT CCTTTTCACT CCATTTTGGC 1020
CAGAAACAGA AGTCCTCCGT GATTTATATT TTTACTAGAA TCTTTTAAAG GGGCACAAAT 1080
GGGGGTGTTT TGCAGGCATA CAGAAGCCCC CGTCACTCCT CCCGCCTTGT CTCTGAACCG 1140
CTGTGGGGTG GGGAGGGGTC TCTTCTCTCT CCAACCCACA TCACTTTCAC CCCCCGCCGG 1200
CCAAGGCTGC GTTTCCCTCG CCCCCACCCC AGTCCCCCGC GTTGGTAGTG GGATCGGTTT 1260
GGTATTCTGA GGCTTCTCTC ATTTCTCCTT TATCACCATC TGCCCCACAG CAGGCAGGCC 1320
CGGAGCCTCT GCAGAAGGGG GAACCGGGTG CAGGCCCAAC GCCGGTCTCT CAGTGTGGCA 1380
GCCTTGCGCG CGAGCAGAAG CAGAAGGCCT AGTTCCTACT CTGCAGCCTT GGCTGCCGGG 1440
CACGGAGAAC GTTTTAGCAG AAACACCTCT GCAAAACCAC TTCCTGGCCC GGGCCCAGCC 1500
AAACACCATC TTCTCCTCCA CCCCAGGGCT CCGCCCCCAT CTCCAGGCTC AGCCCAGCAC 1560
CCCCACCCCC GAAACCCCCA GCCCCACTGC ATCTGCCCTG GCCATCTGCC TCCGCCCTGC 1620
CTCGCTAACA CAGTTATTAA TGAGCAATTT TCCTGTAATT ACAACGCAGT TATGCCAGTT 1680
ACCCCGACCT GCTGACAGAG AGCATTCACT TCCATGTGGC ACTAGCCCCC AGGCCTGAGA 1740
GGACGCAAAC ACTTGCCCCT CATTCGCTGC CCCCACCCCC ACTCTGCCAG CCAGCACCAC 1800
CCTCCACCCA CTCTAGGCCC TTAAGAAAGG AGGGAAGGGC CGCGGGGAGG AGCTCTCAGA 1860
TCCCGAGGCC CCACTCCCCC TGCAAGGAAG GCTGTGAGCT CGGCCCCAGC CCACCTGCCA 1920
GCTCCCCAAA CACCTCCCAC CTCCCTCCGC CGCCTCCTGA AGGGACTACA CTCCCCTGGC 1980
TCCTCCAAAA TCCGCTAATG AACAGCAGGC GCAGAGGCTC CGCCACCGGC GTGCTCCTGG 2040
CCTCAGCCCT CCCTGTTCTG AAACCGCCTT TGCTAAGACG GTAGTAGTGA GGAATCACGA 2100
CAGTGGCAGA GGCCAACCTG ACCCGCTCCA CCTGCCTCCA CCCCAACCCG CCCGGCTGCT 2160
TCCTGAGCGT GGGCCAAACT AACTTTGACA GGAACTTAGT TTACAGTTTA AGTTGGGAAC 2220
AAAAAGGATA ACAGCCCCTC CCCAAAACAG ATTCCCTCCT CGCTTGGGGG GACCAGTCCC 2280
GTTGTAAAAC CGACAAATAA CAGCAGGATT AGGAATTCCG GCTCAGGATT CACGCAGCCA 2340
GACGCCACAG GACTCCTCCC CAGCCGCTCC TGTATATGAC GTCACCGCCG TAAGACCACA 2400
GGACACCGCC CCAGCCGCGC CTGTAGATGA CGTCACCATC GTAAGACCAC AGGACCCTTC 2460
CCAGCCGCTC CTGTATATGA CGTCACCGCC GTAAGACCAC AAGTCACCGC CCCAGCCGCT 2520
CCTGTAGATG ACGTCACCAC AGTAAGACCA CAGGATACCG CCCCAGCCGC GCCTGTAGAT 2580
GACGTCACCA TCGTAGGCCC ACAGGACCCT TCCCAGCCGC TCCTGTGGAT GACGTCACCG 2640
CCGTAGGACC TAAGATTGAT GCTGGAGAGG TTCTTCAGAC CCTGCGTTCT GACGGCTCCG 2700
CTGGCACCAC CCAGACGGGT AAACTAGCTC TTCCGGTCTG TGGCCCTCAC AGGAACCGAC 2760
TCGGTGCAGG AGGACAGCTT CAGCCCCTGT GATTTCATCC CCGACCAACC AGCCAGCACT 2820
CCCCACTCCC TAGCCCCCTG CCTGCCAAAC TATCTTTTAA AAAACTCCAG TTTCCAAATT 2880
TTCAGGGAGG CTGATTTGAG TAATAATAAA ACTCCAGTCT CCTGCTAGCT GGCTCTGGAT 2940
GCACTAGACT CTATTGCAAT TCTCCTGTCC TGATAAATCG GCTGTCAGGC AAGAAGAACC 3000
CGTTGGGTGG TTACAGTTTC AAGGCTATAT TCAGAGAACT ATCCACTAAT 3050